QCM
ADPT icon

Quantinno Capital Management’s Adaptive Biotechnologies ADPT Stock Holding History

Quantinno Capital Management’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.03M Buy
47,905
+6,367
+15% +$97.5K ﹤0.01% 2538
2026
Q1 		$577K Buy
41,538
+700
+2% +$11.2K ﹤0.01% 2609
2025
Q4 		$663K Buy
40,838
+2,716
+7% +$44.3K ﹤0.01% 2134
2025
Q3 		$570K Buy
38,122
+7,611
+25% +$92.7K ﹤0.01% 1891
2025
Q2 		$355K Buy
30,511
+8,534
+39% +$77.5K ﹤0.01% 1900
2025
Q1 		$163K Buy
21,977
+5,289
+32% +$40.6K ﹤0.01% 1932
2024
Q4 		$100K Buy
+16,688
New +$92K ﹤0.01% 1617

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Quantinno Capital Management's ADPT Position: Q2 2026 in Review

Quantinno Capital Management increased its Adaptive Biotechnologies (ADPT) stake by 15% in Q2 2026, buying an estimated $97.5K and bringing the position to 47,905 shares worth $1.03M. The position accounts for ﹤0.01% of the portfolio, ranked #2538.

Quantinno Capital Management first reported a position in ADPT in Q4 2024 and has held it in 7 quarters since. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Quantinno Capital Management held 47,905 shares of Adaptive Biotechnologies worth $1.03M as of Q2 2026.
  • Quantinno Capital Management bought 6,367 Adaptive Biotechnologies shares in Q2 2026, an estimated $97.5K.
  • Adaptive Biotechnologies made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #2538 holding.
  • Quantinno Capital Management first reported a position in Adaptive Biotechnologies in Q4 2024 and has held it in 7 quarters since.
  • 300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.